Statement/Regulatory AdmissionAflibercept-Biosimilar FYB203 / AHZANTIVE®/ Baiama® receives positive CHMP Opinion from EMA15-Nov-2024 / 18:18 CET/CESTDisclosure of an inside information acc. to Article ...
Quotient Sciences, a leading global drug development and manufacturing accelerator, today announced the installation of Centillion’s™ proprietary Biofoundry-in-a-Box (BiaB™), the first multi-product ...
Seasoned Behavioral Health Leader Joins THIRA Health, Strengthening Commitment to Comprehensive Mental Health Care for Women and AdolescentsBELLEVUE, WA / ACCESSWIRE / November 15, 2024 / THIRA Health ...
Aviva Aesthetics provides med spa owners with an alternative to private equity CHICAGO, IL and FULTON, MD / ACCESSWIRE / November 15, 2024 / DuneGlass Capital, a healthcare services-focused ...
Primary analysis data in potentially pivotal GBM study with lead program, Berubicin, on track for the first half of 2025Company strengthens cash position to extend runway to fund operations beyond ...
BEIJING, CHINA / ACCESSWIRE / November 15, 2024 / CASI Pharmaceuticals, Inc. (Nasdaq:CASI) ("CASI" or the "Company"), a Cayman incorporated biopharmaceutical company specializing in the development ...
SHELTON, CT / ACCESSWIRE / November 15, 2024 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), reports that it has filed its Quarterly Report on Form 10-Q for the quarter ending September 30 ...
TORONTO, ON / ACCESSWIRE / November 15, 2024 / Justera Health Ltd. (CSE:VTAL)(OTC PINK:SCRSF) ("Justera"or the"Company") is pleased to announce the changes to the leadership to the Company.The Company ...
BOULDER, CO / ACCESSWIRE / November 15, 2024 / Encision Inc. (OTC PINK:ECIA), a medical device company owning patented Active Electrode Monitoring (AEM®) Technology that prevents dangerous radiant ...
Sanofi today announced that Rippon Ubhi has been appointed as the new Chair of the European Medicines Group (EMG). Rippon will continue her role as Country Lead for Sanofi UK & Ireland alongside this ...
Eisai Europe Ltd. and Biogen Inc. announced today that a positive opinion has been received from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) ...
A new report from the Office of Health Economics (OHE) reveals how NICE may be systematically undervaluing medicines for severe medical conditions, including terminal cancer, compared to how the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback